CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy

08 May 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586

08 May 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics to Hold Annual Meeting of Stockholders

07 May 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 May 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

29 Apr 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce First Quarter Results on May 8, 2024

24 Apr 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress

10 Apr 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

05 Apr 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

05 Apr 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 Apr 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

01 Apr 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session

25 Mar 2024 08:15:04 By Nasdaq GlobeNewswire

Cytokinetics to Participate in March Investor Conferences

04 Mar 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Mar 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

29 Feb 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials

28 Feb 2024 07:30:00 By Nasdaq GlobeNewswire

Cytokinetics Reports Fourth Quarter 2023 Financial Results

27 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Announce Fourth Quarter Results on February 27, 2024

13 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program

29 Jan 2024 07:30:00 By Nasdaq GlobeNewswire